fluoxetine has been researched along with Osteoporosis in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine was used for pharmacologic induction of osteoporosis and surgical oophorectomy (OVX) was used for hormonal induction of osteoporosis." | 5.91 | Non-psychoactive Cannabidiol Prevents Osteoporosis in an Animal Model and Increases Cell Viability, Proliferation, and Osteogenic Gene Expression in Human Skeletal Stem and Progenitor Cells. ( Buchalter, DB; Dankert, JF; Ihejirika, Y; Ihejirika-Lomedico, R; Kirby, DJ; Leucht, P; Mehta, D; Muiños-López, E; Patel, K, 2023) |
| "Fluoxetine was used for pharmacologic induction of osteoporosis and surgical oophorectomy (OVX) was used for hormonal induction of osteoporosis." | 1.91 | Non-psychoactive Cannabidiol Prevents Osteoporosis in an Animal Model and Increases Cell Viability, Proliferation, and Osteogenic Gene Expression in Human Skeletal Stem and Progenitor Cells. ( Buchalter, DB; Dankert, JF; Ihejirika, Y; Ihejirika-Lomedico, R; Kirby, DJ; Leucht, P; Mehta, D; Muiños-López, E; Patel, K, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ihejirika-Lomedico, R | 1 |
| Patel, K | 1 |
| Buchalter, DB | 1 |
| Kirby, DJ | 1 |
| Mehta, D | 1 |
| Dankert, JF | 1 |
| Muiños-López, E | 1 |
| Ihejirika, Y | 1 |
| Leucht, P | 1 |
| Ferroni, L | 1 |
| Gardin, C | 1 |
| Bellin, G | 1 |
| Vindigni, V | 1 |
| Pavan, C | 1 |
| Zavan, B | 1 |
| Studd, J | 1 |
1 review available for fluoxetine and Osteoporosis
| Article | Year |
|---|---|
'PROFOX'--the post HRT nightmare.
Topics: Alendronate; Depression; Estrogen Replacement Therapy; Estrogens; Female; Fluoxetine; Humans; Osteop | 2011 |
2 other studies available for fluoxetine and Osteoporosis
| Article | Year |
|---|---|
Non-psychoactive Cannabidiol Prevents Osteoporosis in an Animal Model and Increases Cell Viability, Proliferation, and Osteogenic Gene Expression in Human Skeletal Stem and Progenitor Cells.
Topics: Animals; Cannabidiol; Cell Proliferation; Cell Survival; Fluoxetine; Gene Expression; Humans; Mesenc | 2023 |
Effects of novel antidepressant drugs on mesenchymal stem cell physiology.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Adult; Antidepressive Agents; Cell Differentiation; Cell P | 2019 |